TY  - GEN
AU  - Kuiper,Justine L
AU  - Ronden,Merle I
AU  - Becker,Annemarie
AU  - Heideman,Daniëlle A M
AU  - van Hengel,Peter
AU  - Ylstra,Bauke
AU  - Thunnissen,Erik
AU  - Smit,Egbert F
TI  - Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor
SN  - 1472-4146
PY  - 2015///0520
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Biopsy
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Carcinoma, Squamous Cell
KW  - enzymology
KW  - DNA Mutational Analysis
KW  - Disease Progression
KW  - Drug Resistance, Neoplasm
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Fatal Outcome
KW  - Female
KW  - Genetic Predisposition to Disease
KW  - Humans
KW  - Lung Neoplasms
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Mutation
KW  - Phenotype
KW  - Protein Kinase Inhibitors
KW  - Quinazolines
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Case Reports; Letter
UR  - https://doi.org/10.1136/jclinpath-2015-202866
ER  -